Back to search

United Kingdom· GB-APID-30717911000001107

Procysbi 25mg gastro-resistant capsules

A mercaptamine product containing mercaptamine, registered in United Kingdom by Chiesi Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC A16AA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedProcysbi 25mg gastro-resistant capsul…ATCA16AA04REGISTER NO.GB-APID-3071791100000…PACKS LISTED5CHECKEDSeptember 13, 2026

Where it is registered

Mercaptamine is registered in 14 of 19 countries.

Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Mercaptamine · ATC A16AA04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mercaptamine costs, country by country.

Normalised to the WHO defined daily dose (2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Mercaptamine · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$589.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Mercaptamine
Manufacturer
Chiesi Ltd
Country
United Kingdom (GB)
ATC code
A16AA04
ATC class
Mercaptamine
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 5

  • gtin
    5028613003077
  • gtin
    04150085016123
  • gtin
    05028613003077
  • gtin
    5028613003527
  • gtin
    05028613003527

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mercaptamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mercaptamine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cystadrops, Cystagon
  • Liechtenstein · Cystadrops, Cystagon
  • Norway · Cystadrops, Cystagon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/99611e8e-a77e-46a1-be96-6e82dcdf438e
GET /v1/drugs/99611e8e-a77e-46a1-be96-6e82dcdf438e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "30717911000001107",
  "desc": "Procysbi 25mg gastro-resistant capsules (Chiesi Ltd)",
  "form": "Gastro-resistant capsule",
  "vpid": "30738211000001108",
  "source": "dmd",
  "vtm_id": "776687008",
  "strength": "25 mg",
  "substance": "Mercaptamine",
  "ingredient": "Mercaptamine bitartrate",
  "supplier_code": "9052511000001105"
}

See everything about mercaptamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.